Ken leads seed-stage Neuralpositive in its mission to enable hyper-personalized playlists of music to reduce anxiety. Prior, Ken spent 17 years in healthcare and lifesciences as a senior executive, venture capitalist, and board member for multiple, successfully exited (>$1.5B) startups. Past roles include the CEO of Three Lakes Partners; thought leader for professional organizations such as the American Association for Clinical Chemistry and Association for Molecular Pathology; and Advisor to the White House on Fostering Innovation. He also founded and manages the premier Analyst events for molecular diagnostics and microbiology, and manages panels focused on next-generation technologies and trends at the annual JP Morgan Healthcare Conference. He received his Ph.D. in Biochemistry and Molecular Biology and an M.S. in Neurobiology and Physiology from Northwestern University, and his M.B.A. from the Kellogg School of Management.